| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Townsend Richard Nolan is a Chief Executive Officer at LXEO. Recent filings cover 0 purchases and 18 sales. Those positions are worth an estimated $1.9M at current prices.
Our model assigns Townsend Richard Nolan a strong insider score of 74/100, based on 14 past trades. Over a 12-month horizon, 54.5% of those trades were profitable, with an average 12-month return of +25.4%.
Townsend Richard Nolan's largest disclosed position is in LXEO as Chief Executive Officer, worth about $1.9M. The recent filings there lean toward selling, a net 107,395 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 11, 2024 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 55,000 | $16.79 | $923,387.71 | -9.2% | -51.3% | -74.4% | |
| Jun 10, 2024 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 5,000 | $17.65 | $88,263.82 | -1.4% | -42.2% | -75.4% | |
| May 13, 2024 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 5,000 | $13.22 | $66,093.00 | -2.8% | -11.7% | -79.1% |